Smart Dividend Portfolio Edition #89: Income Edge
1
Dear Investor,
Welcome to the 89th edition of TipRanks’ Smart Dividend Portfolio & Newsletter.
1
1
Market-Moving News: Dec 01, 2025
U.S. stocks ended the week in the black as markets cheered signs of slower inflation and rising odds of a Federal Reserve rate cut in December. The S&P 500 (SPX) gained 0.54%, the Nasdaq (NDX) rose 0.78%, and the Dow Jones Industrial Average (DJIA) added 0.61%. Treasury yields eased, with the 10-year note closing at 4.00%.
Economic data showed cooling trends in both prices and growth. The inflation rate stood at 3.01%, unemployment edged up to 4.40%, and real GDP growth came in at 3.80%. Retail sales rose a modest 0.07%, signaling that consumers are still spending, but at a slower pace. The Federal Funds Rate was 4.09%, down slightly from September.
In commodities, silver (XAGUSD) surged 6.49% to $57.09 per ounce, hitting record highs for the year. Gold (XAUUSD) rose 1.29%, while oil prices slipped 0.29% to $58.48 a barrel. Natural gas jumped 6.67%, reflecting colder weather forecasts and strong export demand.
The story of the week was the pullback in major technology names after a strong year of gains. Nvidia (NVDA) fell 1.81%, its worst month since 2022, as investors rotated away from high-growth stocks. The decline followed reports that Meta Platforms (META) may be shifting its AI chip purchases to Alphabet (GOOGL) instead of Nvidia, sparking talk that Nvidia’s market dominance could face its first real test.
Meanwhile, Alphabet climbed 13.8% for the month after revealing its upgraded Gemini 3 AI model and a potential new chip deal with Meta. Broadcom (AVGO) also gained 7.6% on expectations it will benefit from demand tied to Google’s AI projects. However, investors grew more selective, with many looking to take profits from names that have thus far led the 2025 rally.
The rotation weighed on the broader AI trade, but it also reflected healthy rebalancing. Analysts said investors are adjusting to the idea that AI spending growth may spread to more firms and chip designs. The shift helped steady markets as traders prepared for what some call the end of the year “Santa Claus rally.”
1
1
1
This Week’s Quality Dividend Stock Idea
IDEX Corp. (IEX) is a U.S.-based industrial technology company that designs and manufactures mission-critical components, fluidics systems, and specialty engineered products. Its end markets include industrial, municipal, life sciences, and energy markets. IEX operates through a collection of highly specialized businesses known for their niche market leadership, consistent innovation, and strong aftermarket demand.
1
Precision Power
IDEX traces its origins to 1988, when it was formed through a series of acquisitions centered on precision engineering and mission-critical fluid handling. From the beginning, the company relied on a decentralized operating model that allowed each business to maintain technical expertise while benefiting from shared capital discipline and strategic oversight. This structure supported steady expansion through the 1990s and early 2000s as IDEX added specialized businesses in pumps, metering, dispensing, fire and safety, and industrial components. These moves diversified its end markets and strengthened recurring aftermarket sales, helping build the foundation for durable earnings growth.
Beginning in the late 2010s, IDEX shifted its portfolio toward higher-value engineered technologies serving health, science, semiconductor, and analytical applications. This transition accelerated over the past decade through a series of strategically important acquisitions. In early 2021, the company acquired Abel Pumps, adding specialized reciprocating positive displacement pumps to its Fluid & Metering Technologies segment. Two years later, in December 2023, IDEX expanded its material science capabilities by acquiring STC Material Solutions, strengthening its position in engineered ceramics and composite components.
The company’s largest wave of portfolio transformation came over the past two years. In September 2024, IDEX completed the acquisition of Mott Corp., significantly enhancing its applied material science technologies, particularly in microfiltration for high-value markets such as the energy transition. The addition of Mott also helped IDEX secure major contracts in wastewater filtration. The momentum continued in July 2025 with the acquisition of Micro-LAM, a manufacturer of laser-assisted machining systems and ultra-precision optical tools. This further bolstered the company’s optics and laser-machining capabilities.
Throughout this period, IDEX maintained a consistent strategy: reinvest in niche, defensible engineered technologies that deepen its presence in growing industrial, scientific, and clean-technology markets.
1
Niche Advantage
IDEX operates a differentiated industrial technology model built around niche leadership and high-margin engineered products. The company designs and manufactures mission-critical components, including precision pumps, microfluidics, filtration systems, fire and safety equipment, and specialty optical and material-science technologies, that enable essential processes across industrial, municipal, life sciences, semiconductor, and energy markets. These products perform indispensable functions, giving them strong pricing power and steady recurring demand.
Operations are organized into three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP), each comprising specialized reporting units with deep domain expertise. HST has become the fastest-growing segment, supported by acquisitions such as Mott and Micro-LAM, which expanded exposure to advanced filtration, semiconductor tooling, precision optics, and analytical instruments with secular growth tailwinds. FMT provides stability through pumps, water systems, metering technologies, and industrial and municipal equipment engineered for reliability, helping maintain customer retention and recurring revenue. FSDP includes fire suppression, rescue tools, and engineered fastening products, benefiting from steady replacement cycles and municipal and industrial safety spending.
Across all segments, IDEX emphasizes high-mix, low-volume manufacturing, enabling customization and premium pricing. Its decentralized structure accelerates innovation and keeps overhead lean, while targeted restructuring initiatives have further improved productivity.
1
Growth Engines
IDEX’s 80/20-driven growth strategy is anchored on three pillars designed to accelerate performance and focus on high-value opportunities. The first pillar targets high-growth markets, with strategic acquisitions expanding capabilities and shifting the portfolio away from traditional industrial segments. Notable examples include Micro-LAM in optics for the Material Sciences Solutions (MSS) segment, enabling the company to pursue faster growth with mid-single-digit organic revenue increases, compared with historical low-single-digit growth tied to broader industrial indicators like the ISM Industrial Index.
The second pillar focuses on integrating technologies and market access through platforms like MSS, which combine material forming, shaping, and coating to drive transformative growth. Muon, a miniaturization technology business, mitigates pressures in semiconductor lithography via productivity gains and new wins in data center cooling and optical switching, achieving profitability above the Health & Science Technologies (HST) segment average. These differentiated offerings also provide pricing power, protecting margins even when end markets soften.
The third pillar emphasizes balanced capital allocation, shifting from large acquisitions toward smaller bolt-on deals, operational optimization, and shareholder returns, while maintaining a strong pipeline for proprietary growth ideas.
IDEX’s growth platforms now generate roughly 50% of revenue and are expected to produce disproportionate organic growth. Intelligent Water, part of the Fluid & Metering Technologies segment, posted high single-digit Q3 revenue growth, integrating flow monitoring, inspection, and analytics to help municipalities improve efficiency and plan capital projects, with a positive outlook for 2026. MSS continues to fuel HST growth by addressing critical “jobs to be done,” offering precision optics and materials solutions that enhance productivity and operational outcomes. Performance Pneumatics (Airtech) specializes in pneumatic pressure technologies, including vacuum pumps, regenerative blowers, compressors, and valves, serving markets such as alternative energy, food processing, medical, packaging, and transportation. Airtech led HST orders and sales growth in Q3, supporting power generation for data centers. Together, these platforms demonstrate IDEX’s pivot toward high-growth, technology-driven markets with strong recurring demand and margin potential.
Pricing remained a net tailwind in Q3, contributing approximately 3.5% to revenue growth, with 1.5% from base pricing and 2% from tariffs. This reflects the company’s ability to pass on costs despite ongoing cost pressures and tariff impacts. Such pricing power highlights the differentiation and value of IDEX’s products, enabling the company to defend profitability even when raw material or operational costs rise.
1
Platform Power
Over the past three years, IEX’s revenues have grown at a CAGR of 3.5% supported by strategic acquisitions, most notably Mott Corporation, and steady organic expansion in high-growth areas such as HST and FSDP. Innovation and market reach reinforced this trajectory. However, adjusted diluted EPS has declined by 5.7% as margins came under pressure from operational challenges, softer industrial demand, and lower volumes in industrial equipment, all of which weighed on net income and profitability.
In the third quarter of 2025, IDEX bucked these slipping margin trends. The company delivered record sales of about $879 million, an increase of 10% year over year, surpassing consensus expectations. Organic orders grew 7%, driven by HST and FMT segments. The improvement resulted in a 5% increase in organic sales, led by a double-digit surge in Health and Science Technologies, which achieved a record quarter. By contrast, FSDP reported a decline in sales, reflecting softness in certain international markets.
Margins remained resilient despite changes in volume and mix. Adjusted gross margin edged slightly lower to 44.5% from 44.6% a year earlier due to an unfavorable mix, but productivity initiatives helped mitigate most of the pressure. Moreover, adjusted EBITDA margin improved by 40 basis points to approximately 27%, supported by stronger price–cost dynamics, operating leverage, and contributions from IDEX’s platform optimization and cost-containment programs. These initiatives delivered $17 million in savings during the quarter and are on track to reaching a run-rate of about $20 million in the fourth quarter.
Net income increased to $127.8 million, and adjusted diluted EPS rose 7% to $2.03, exceeding Street estimates. Growth was led by a 22% increase in sales in Health and Science Technologies and solid performance in Fluid and Metering Technologies. Within HST, organic orders increased 5%, and organic sales rose 10%, supported by strength across life sciences, pharmaceuticals, data centers, semiconductor consumables, and space and defense. Segment EBITDA margin expanded by 120 basis points to 27.7%, helped by strong execution and the continued integration of Micro-LAM, which is creating opportunities for further optimization-driven margin gains.
FMT segment posted an 4% increase in organic sales and 5% growth in sales, with EBITDA margin improving 90 basis points to 33.7%. Results were driven by Intelligent Water projects, though industrial demand remained rangebound as customers delayed larger commitments. However, Fire & Safety/Diversified Products faced a more difficult quarter: organic orders rose 7%, but sales fell 5%, leading to a 200-basis-point EBITDA margin decline to 27.1% due to volume deleverage and softer non-U.S. markets.
IDEX continued to generate strong cash flow, producing $189 million in free cash flow and converting more than 100% of adjusted net income. Management reaffirmed its target of achieving at least 100% free cash flow conversion for 2025. Backlog levels held steady sequentially, with roughly 50% of quarterly revenue typically booked at the start of each period, a structure consistent with IDEX’s historical visibility. Demand trends varied: municipal water, data centers, semiconductor maintenance, pharmaceuticals, and space and defense strengthened, while semiconductor lithography, life sciences, dispensing, and non-U.S. fire and safety markets softened.
The balance sheet remained a source of strength. IDEX ended the quarter with about $1.1 billion in available liquidity, including roughly $600 million in cash and access to a $500 million revolving credit facility. Gross leverage stood at 2.1x, and the company expects to bring this ratio below 2x in the coming quarters.
Looking ahead to FY25, IDEX narrowed its adjusted diluted EPS outlook to $7.88 at midpoint, within its prior guidance range of $7.90 per share. Management expects organic sales to grow by around 1%, with adjusted EBITDA margin projected between 26.5% and 27.5%. The full-year savings plan of more than $60 million, tied to platform optimization and cost containment, remains firmly on track, supporting the company’s continued focus on operational discipline and cash-flow strength in the year ahead.
Over the longer term, IDEX aims to achieve mid-single-digit organic growth, up from its historical 3–4%, supported by targeted growth platforms. Incremental margins are expected to remain strong, exceeding 30% on a consolidated basis, with 35–40% in HST backed by robust demand. Management remains confident that EPS growth will be driven by organic leverage and disciplined capital deployment, including share repurchases and strategic investments.
1
Dividend Drive
IDEX has established a long record of returning cash to shareholders, having paid uninterrupted dividends for more than 25 years and raising its payout annually for the past 16 years. Over the last decade, the dividend has grown at an annualized rate of 8.79%, supported by consistent earnings and strong free cash flow. Based on adjusted earnings, the company distributes roughly 36% to shareholders, a level that reflects both financial discipline and the flexibility to reinvest in high-margin growth platforms. IDEX’s current dividend yield stands at 1.7%, above the industrials sector average of 1.27%, underscoring the company’s relative income appeal within a typically low-yielding industry.
In the most recent quarter, the company maintained its standard quarterly payout, distributing dividend of $0.71 per share, which equates to an annualized dividend of $2.84. Alongside its dividend program, IDEX has expanded its use of share repurchases as part of its broader capital allocation strategy. During the third quarter of 2025, the company repurchased $75 million worth of shares, bringing year-to-date buybacks to $175 million. Management also raised the repurchase authorization to $1 billion, giving the company substantial capacity to offset dilution and return additional capital when market conditions are favorable.
Despite these shareholder-friendly actions and record Q3 2025 sales, IDEX’s share price has declined nearly 25% over the past year. The pullback reflects several headwinds, including cautious full-year guidance that tempered sentiment even as quarterly results exceeded expectations, as well as margin pressure from cost inflation and an unfavorable mix shift. Broader macroeconomic uncertainties, including tariff risks, have further added to investor caution.
From a valuation perspective, IDEX currently trades at more than a 20% discount to its historical averages based on non-GAAP trailing and forward P/E ratios, trailing and forward EV/EBITDA. This indicates that the market is currently assigning a lower premium to IDEX despite its durable margins, recurring revenue exposure, and expanding presence in high-growth filtration, optics, and life-science technologies.
Compared to peers like Roper Technologies, Danaher, and Parker-Hannifin, IDEX sits at the lower end of the valuation range based on non-GAAP trailing and forward P/E and forward EV/EBITDA ratios. For investors, this combination of discounted multiples and high-quality fundamentals may imply a favorable risk-reward setup, particularly if the company continues to execute on its growth strategy and integrate recent acquisitions that strengthen its long-term earnings profile.
Analysts remain optimistic regarding IDEX’s outlook as the company increasingly positions itself as a unified platform of specialized capabilities rather than a collection of individual brands. This evolution has strengthened the IDEX identity in the eyes of customers and reflects management’s willingness to reexamine long-standing organizational structures to better align the business for future growth. These efforts are seen as enhancing the company’s strategic flexibility and reinforcing its long-term earnings potential.
Consensus estimates point to roughly 10% upside from current share levels, with some analysts projecting gains of up to 21%. A discounted cash flow analysis provides additional support for this view, suggesting the stock may be trading at an approximately 18% discount to its intrinsic value.
1
Investing Takeaway
IDEX Corp. stands out as a compelling income-focused investment due to its long track record of returning cash to shareholders through consistent dividends and share repurchases. The company has paid uninterrupted dividends for more than two decades, with a history of annual increases, reflecting disciplined earnings generation and strong free cash flow. Alongside dividends, IDEX has actively repurchased shares, enhancing total shareholder returns and demonstrating flexibility in capital allocation. Even amid market pullbacks and segment-specific headwinds, the company maintains robust cash flow and a strong balance sheet, supporting ongoing income distribution. For investors seeking reliable cash returns, IDEX combines durable, recurring revenue streams from niche industrial and technology markets with a shareholder-friendly approach, offering both income stability and the potential for capital appreciation as the company continues to execute its strategic growth initiatives.
1
Dividend Investor Portfolio
1
Portfolio News
▣ Bank of Nova Scotia (BNS) is expected to announce its Q4 results on December 2. Analysts currently expect BNS to report earnings of $1.32 per share and about $6.7 billion in revenue. Sentiment is cautiously optimistic as strength in wealth-management and global banking divisions could help offset continued pressure on loan growth and credit-cost risks, setting the stage for a possibly constructive quarter.
▣ Kroger (KR) is expected to announce its Q3 results on December 4. Analysts forecast adjusted EPS of about $1.03, signaling a modest improvement from the $0.98 delivered a year earlier. Revenue is projected to land near $34.3 billion, reflecting stable growth across grocery, fresh food, pharmacy, and e-commerce. Recent quarters have shown that Kroger’s investments in digital fulfillment and margin management are gaining traction, helping offset inflation-driven cost pressures.
▣ Qualcomm’s (QCOM) push to diversify beyond its traditional mobile-chip business gained meaningful traction this week as the company moved a step closer to acquiring Alphawave IP Group. The proposed $2.4 billion deal is central to Qualcomm’s strategy to expand deeper into data-center connectivity and AI infrastructure, areas that are becoming increasingly important as workloads shift toward high-performance computing. The transaction advanced after regulators in South Korea granted approval, adding to the list of jurisdictions that have already cleared the deal. If completed, the acquisition would give Qualcomm access to high-speed connectivity technology critical for next-generation AI systems, strengthening its competitive position beyond smartphones.
1
Recent Trades
None at the moment, although we are considering adding a stock to our portfolio when the market conditions allow for an attractive entry point. Stay tuned.
1
1
Portfolio Attributes
| Dividend Portfolio Yield |
Expected Dividend Growth | Expected Annual Income |
| 3.99% | +5.78% | $5,929.82 |
| Yield-on-Cost Adjusted, Weighted |
Average Analyst 12-Month Growth Outlook | 10K Per Stock at the Time of Purchase |
Current Portfolio
| Name | EX-Dividend Date | Payment Date | Yield on Cost | Annual DPS |
| Automatic Data Processing (ADP) | Dec 12, 2025 | Jan 01, 2026 | 2.46% | $6.80 |
| Amgen (AMGN) | Nov 21, 2025 | Dec 12, 2025 | 3.27% | $9.52 |
| BlackRock (BLK) | Mar 09, 2026 | Mar 24, 2026 | 2.61% | $20.84 |
| Bank of Nova Scotia (BNS) | Jan 07, 2026 | Jan 29, 2026 | 5.98% | $3.21 |
| EOG Resources (EOG) | Jan 16, 2026 | Jan 30, 2026 | 3.06% | $4.08 |
| ExxonMobil (XOM) | Feb 12, 2026 | Mar 10, 2026 | 3.64% | $4.12 |
| IBM (IBM) | Feb 10, 2026 | Mar 10, 2026 | 3.14% | $6.72 |
| JPMorgan Chase (JPM) | Jan 06, 2026 | Jan 29, 2026 | 3.43% | $6.00 |
| Kroger (KR) | Feb 17, 2026 | Mar 03, 2026 | 3.08% | $1.40 |
| Lockheed Martin (LMT) | Mar 03, 2026 | Mar 30, 2026 | 2.85% | $13.80 |
| PepsiCo (PEP) | Dec 09, 2025 | Jan 06, 2026 | 3.8% | $5.69 |
| Philip Morris (PM) | Dec 26, 2025 | Jan 13, 2026 | 6.06% | $5.88 |
| Qualcomm (QCOM) | Dec 08, 2025 | Dec 22, 2025 | 2.36% | $3.56 |
| VICI Properties (VICI) | Dec 17, 2025 | Jan 09, 2026 | 5.22% | $1.8 |
| Verizon (VZ) | Jan 12, 2026 | Feb 03, 2026 | 6.09% | $2.76 |
NameEX-Dividend DatePayment DateYield on Cost Annual DPS
1
1
1
Click here for more stock market analysis from TipRanks Macro & Markets research analyst Yulia Vaiman
1
Disclaimer
The information contained in this article represents the views and opinions of the writer only, and not the views or opinions of TipRanks or its affiliates and should be considered for informational purposes only. TipRanks makes no warranties about the completeness, accuracy, or reliability of such information. Nothing in this article should be taken as a recommendation or solicitation to purchase or sell securities. Nothing in the article constitutes legal, professional, investment, and/or financial advice and/or takes into account the specific needs and/or requirements of an individual, nor does any information in the article constitute a comprehensive or complete statement of the matters or subject discussed therein. TipRanks and its affiliates disclaim all liability or responsibility with respect to the content of the article, and any action taken upon the information in the article is at your own and sole risk. The link to this article does not constitute an endorsement or recommendation by TipRanks or its affiliates. Past performance is not indicative of future results, prices, or performance.
